Sophia Genetics goes public in $234M IPO, two other biotechs delay

Amid what's shaping up to be a record year for IPOs, just one local biotech companies hit the Nasdaq on Friday, while two others that were initially scheduled to go public put off their listings. Genomics testing firm Sophia Genetics rang the bell on Friday morning. Co-headquartered in Boston and Lausanne, Switzerland, Sophia raised $234 million in its IPO, selling 13 million shares at $18 each, the midpoint of its range. J.P. Morgan, Morgan Stanley, Cowen and Credit Suisse backed the list ing. Sophia…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news